Description
1) create a original response to the following question: I included classmate responses so you could see what others are saying
2)next, I need you to actually comment back to my classmates responses with some meaningful comment.
Question: GINA 2019 is going to create a significant uproar for the first line therapy for intermittent exacerbations. Based on your limited exposure to Asthma management- what do you think is/are the potential concerns about this new recommendation?
Unformatted Attachment Preview
Purchase answer to see full attachment
Explanation & Answer
Attached.
GINA 2019 - Outline
Thesis Statement: Asthma remains a significant health problem around the world and the
Global Initiative for Asthma (GINA) has been working to address this issue.
I. Initial post
II. Response 1
III. Response 2
IV. Response 3
Running head: GINA 2019
1
GINA 2019
Name
Institution
GINA 2019
2
GINA 2019
Asthma remains a significant health problem around the world and the Global Initiative
for Asthma (GINA) has been working to address this issue. GINA (2019) introduces a paradigm
shift in the first-line therapy of intermittent exacerbations and presents an entirely new approach
to treatment. My main concern about the treatment approach is the issue of evidence leading to
this conclusion. According to Nolan (2019), GINA (2019) bases its recommendations on
emerging evidence of the potential adverse effects of short-acting beta agonist (SABA) overuse.
W...